Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma
Clinical trial NCT00414765 · COMPLETED
Trial details
- NCT number
- NCT00414765
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-03
- Primary completion
- 2010-03-28
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.